How many institutions held VYGR - Voyager Therapeutics, Inc. - Common Stock, $0.001 par value in Q2 2024?

126 institutional investors reported VYGR - Voyager Therapeutics, Inc. - Common Stock, $0.001 par value for Q2 2024. Use the holders table for investor-level position and value details.

Voyager Therapeutics, Inc. - Common Stock, $0.001 par value (VYGR)

Q: What does CUSIP 92915B106 represent in this 13F holders report?

CUSIP 92915B106 is the security identifier for VYGR - Voyager Therapeutics, Inc. - Common Stock, $0.001 par value used to aggregate holder disclosures.

CUSIP: 92915B106

Q2 2024 13F Holders as of 30 Jun 2024

Security type / class: Equity / Common Stock, $0.001 par value
Total 13F shares: 38,132,801
Total 13F value: $301,619,686
Share change: +2,537,219
Put/Call ratio: 75%
SEC-reported price per share: $7.91
Number of holders: 126
Value change: +$18,919,346
Number of buys: 64
Number of sells: 67
Shares outstanding: 61,577,061

Security key

92915B106

Report period

Q2 2024

Institutions

126

Top holders

VYGR full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2026 Voyager Therapeutics, Inc. SEC filings Voyager Therapeutics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 92915B106

Newer quarter: Q3 2026

Recent filing periods:

Q3 2026

Ownership snapshot

Top reported holders of VYGR - Voyager Therapeutics, Inc. - Common Stock, $0.001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

NEUROCRINE BIOSCIENCES INC

Disclosed value leader

NEUROCRINE BIOSCIENCES INC

Comparable rows

0/15

Latest evidence

31 Mar 2024

3/4/5 13F Highest disclosed value: $61,313,509 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

NEUROCRINE BIOSCIENCES INC has the largest disclosed position value at $61.31M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens NEUROCRINE BIOSCIENCES INC's linked filing trail.

Disclosed position value Top 5

NEUROCRINE BIOSCIENCES INC $61.31M

EcoR1 Capital, LLC $36.47M

Third Rock Ventures III, L.P. $22.77M

ARMISTICE CAPITAL, LLC $43.5M

BlackRock Finance, Inc. $40.94M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
NEUROCRINE BIOSCIENCES INC	3/4/5 10%+ Owner 3/4/5	— denominator unverified	$61,313,509 8,575,316 shares	—	23 Feb 2023
EcoR1 Capital, LLC	13F 3/4/5 Company · 10%+ Owner 13F 3/4/5	— denominator unverified	$36,472,353 3,917,546 shares	—	31 Mar 2024
Third Rock Ventures III, L.P.	3/4/5 10%+ Owner 3/4/5	— denominator unverified	$22,774,831 3,185,291 shares	—	02 Feb 2023
Mark J. Levin	3/4/5 Director, 10%+ Owner 3/4/5	— denominator unverified	— 15,000 shares	—	03 Jun 2021
ARMISTICE CAPITAL, LLC	13F Company 13F	— denominator unverified	$43,496,320 4,672,000 shares	—	31 Mar 2024
BlackRock Finance, Inc.	13F Company 13F	— denominator unverified	$40,940,205 4,397,444 shares	—	31 Mar 2024

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

126

38,132,801

Rows available

126

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2024 vs Q1 2024 Across Filers

Q1 2024 holders

132

Q2 2024 holders

126

Holder diff

-6

Investor	Q1 2024 Shares	Q2 2024 Shares	Share Diff	Share Chg %	Q1 2024 value	Q2 2024 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend